Sep 2026· Proceedings of the National Academy of Sciences of the United States of America· Vol 123 38, pp.
e2617361123
· 0 citations· 45 references
Medicine
TL;DR
A role for protein AMPylation in cell signaling and cancer progression is revealed and is shown to be related to cell proliferation and TGF-β-mediated migration.
Abstract
Cell fate is governed by signaling pathways involving diverse protein modifications. However, how protein AMPylation mediates signal transduction in mammalian cells remains largely unexplored. We demonstrate that the protein adenylyltransferase, SELENOO (SelO), is induced by chemotherapy, and has clinical relevance in cancer. In mice, SelO knockout facilitates primary tumor development and metastasis. In cancer cells, the cytosolic fraction of SelO suppresses cell proliferation and migration. Mechanistically, SelO AMPylates CDK5 regulatory subunit-associated protein 3 (Cdk5rap3) at T328, enhancing its interaction with ARF. The interaction competitively reduces ARF associated with the SUMOylation enzyme UBC9, reducing ARF-mediated SUMO1 modifications of Mdm2 and Slug. Concurrently, the strengthened Cdk5rap3-ARF affinity decreases Cdk5rap3 associated with PPM1D, impairing the ability of PPM1D to dephosphorylate Mdm2. These effects collectively lead to destabilization of Mdm2 and Slug proteins, suppressing their downstream pathways relating to cell proliferation and TGF-β-mediated migration. These findings reveal a role for protein AMPylation in cell signaling and cancer progression.
Cyclin-dependent kinase 1 (CDK1), a serine/threonine kinase essential for cell cycle progression, also plays critical roles in DNA damage response, gene expression regulation, and therapeutic resistance. In this study, we identify a previously unrecognized regulatory link between CDK1 and apurinic/apyrimidinic endonu...
Jian-Lin Wang, Jiang Li, Jia Peng et al.· Cell Death & Disease· 0 citations
Receptor-interacting protein kinase 1 (RIPK1) plays a pivotal role in regulating cell survival and death, thereby exerting complex and multifaceted functions in the initiation and progression of cancer. Its expression is frequently dysregulated across diverse malignancies and correlates strongly with poor prognosis, hi...
Jing-Yu Luo, Shu-Ya Song, Ze-Kun Li et al.· Cellular Signalling· 0 citations
It is found that Pdcd4 suppresses tumorigenesis through disrupting mTORC2 complex formation by binding with the rapamycin-insensitive companion of mTOR (Rictor), a core component of the mTORC2 complex.
The FEN1/EIF4A3/MUC1-C axis is established as a novel mechanism driving LUAD progression by concurrently regulating intrinsic malignancy and extrinsic immune evasion, presenting FEN1 targeting as a promising dual-hit therapeutic strategy.
Min Wu, Ben-Meng Wu, Xue-Bing Yan et al.· Cell Death and Disease· 0 citations
In this proposed model, anagrelide remodels the interactome of the PDE3A-SLFN12 complex, which relocalizes and accumulates near the mRNA entry channel of the 43S pre-initiation complex, which provides important mechanistic context for how PDE3A modulators act within the cell.
S. Salmikangas, Iina Lindholm, Nasrin Sultana et al.· Molecular & Cellular Proteom...· 0 citations
Endometrial cancer (EC) is driven by complex genetic and epigenetic alterations, but the specific chromatin-dependent mechanisms that sustain malignant proliferation remain incompletely understood. In this study, we found that lysine demethylase 4A (KDM4A) was upregulated in EC and promoted cell proliferation, migratio...
Jun-Feng Chen, Xiao-Li Wen, Dong-Hai Zhang et al.· International Journal on Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.